Dipeptidyl peptidase IV (DPP-4) inhibition alleviates pulmonary arterial remodeling in experimental pulmonary hypertension

Endothelial to Mesenchymal Transition Contributes to Endothelial Dysfunction in Pulmonary Arterial Hypertension

Robert B. Good, A Gilbane, Sarah L. Trinder et al. · American Journal Of Pathology · 2015 · 354 citations · Full text

Medicine, Molecular Medicine, Physiology +14

Pathology of Pulmonary Hypertension

Rubin M. Tuder, John C. Marecki, Amy Richter et al. · Clinics in Chest Medicine · 2007 · 321 citations · Full text

Medicine, Pathology, Pulmonology +9

A Dipeptidyl Peptidase-4 Inhibitor, Des-Fluoro-Sitagliptin, Improves Endothelial Function and Reduces Atherosclerotic Lesion Formation in Apolipoprotein E–Deficient Mice

Junichi Matsubara, Seigo Sugiyama, Koichi Sugamura et al. · Journal of the American College of Cardiology · 2012 · 272 citations

Medicine, Cardiology, Pharmacology +16

Diet-Induced Adipose Tissue Inflammation and Liver Steatosis Are Prevented by DPP-4 Inhibition in Diabetic Mice

Jun Shirakawa, Hideki Fujii, Kei Ohnuma et al. · Diabetes · 2011 · 248 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Genomewide RNA expression profiling in lung identifies distinct signatures in idiopathic pulmonary arterial hypertension and secondary pulmonary hypertension

Revathi Rajkumar, Kazuhisa Konishi, Thomas J. Richards et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2010 · 198 citations

Life Sciences, Genetics, Molecular Biology +15